This
1 hour module presented by Dr Chan Cheah, provides an overview of
the management of High Grade B-cell Non-Hodgkin Lymphoma, including their
presentation, epidemiology, the common subtypes and the approach to treatment
and management. This module also covers the management of patients with
relapsed and refractory disease, and the prognostic factors for consideration.
Featuring two case studies, this module will provide a key summary of B-cell
Non-Hodgkin Lymphoma.
Course Description
Course Details
Expiry Date: 2021-03-31
Professions: Specialist
Faculty
Dr
Chan Yoon Cheah
MBBS
FRACP FRCPA DMSc
Consultant
Haematologist
Sir
Charles Gairdner Hospital and
the University of Western Australia
Accreditation
The program is endorsed by the Royal Australian College of Physicians (RACP) and the Royal College of Pathologists of Australasia (RCPA) Committee for Joint College training in Haematology (CJCT) and the Haematology Society of Australia and New Zealand (HSANZ).
Fellows of the RACP and RCPA can claim CPD hours.
Learning Objective(s)
At the end of this module, you will be better able to:
- Describe the
biology, clinical presentation, and prognostication of diffuse large
B-cell lymphoma and subtypes - Summarise the key
trials defining the contemporary management of patients DLBCL and variants - Describe an
approach to treatment of DLBCL, primary mediastinal B-cell lymphoma,
primary CNS lymphoma, Burkitt lymphoma and post-transplant
lymphoproliferative disorder - Explain the role
of autologous stem cell transplant in the management of patients with
DLBCL, both in the frontline and relapsed/refractory setting